Abstract

Over the past half-century, medical research on cardiovascular disease (CVD) has achieved a great deal; however, medication adherence is unsatisfactory. Nearly 50% of patients do not follow prescriptions when taking medications, which limits the ability to maximize their therapeutic effects and results in adverse clinical outcomes and high healthcare costs. Furthermore, the effects of medication adherence interventions are disappointing, and tailored interventions have been proposed as an appropriate way to improve medication adherence. To rethink and reconstruct methods of improving medication adherence for CVD, the literature on tailored interventions for medication adherence focusing on CVD within the last 5 years is retrieved and reviewed. Focusing on identifying nonadherent patients, detecting barriers to medication adherence, delivering clinical interventions, and constructing theories, this article reviews the present state of tailored interventions for medication adherence in CVD and also rethinks the present difficulties and suggests avenues for future development.

Highlights

  • During the past half-century, the medications used to treat cardiovascular disease (CVD) have improved greatly; patient adherence to medication recommendations is unsatisfactory, and nearly 50% of patients do not follow prescriptions when taking medications (Sabaté, 2003; Kronish and Ye, 2013)

  • Many studies have concluded that multicomponent interventions are comparatively more effective than single interventions; multicomponent interventions are usually recommended as a suitable way to improve medication adherence, given the concern that medication nonadherence is often multifactorial (Osterberg and Blaschke, 2005; Vonbank et al, 2017; Bosworth et al, 2018; Wang et al, 2019)

  • Focusing on identifying nonadherent patients, detecting barriers to medication adherence, delivering clinical interventions, and constructing theories, this study reviews the present state of tailored interventions for medication adherence in CVD

Read more

Summary

Introduction

During the past half-century, the medications used to treat cardiovascular disease (CVD) have improved greatly; patient adherence to medication recommendations is unsatisfactory, and nearly 50% of patients do not follow prescriptions when taking medications (Sabaté, 2003; Kronish and Ye, 2013). Focusing on identifying nonadherent patients, detecting barriers to medication adherence, delivering clinical interventions, and constructing theories, this study reviews the present state of tailored interventions for medication adherence in CVD.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.